Citation Impact
Citing Papers
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
5 Treatment and prognostic factors in acute myeloid leukaemia
1996
Etoposide: four decades of development of a topoisomerase II inhibitor
1998 Standout
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
2012 Standout
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
1998 Standout
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Pharmacokinetics and bioequivalence of etoposide following intravenous administration of etoposide phosphate and etoposide in patients with solid tumors.
1995
Natural products: An evolving role in future drug discovery
2011 Standout
Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome
2001
The Oklahoma thrombotic thrombocytopenic Purpura-Hemolytic uremic syndrome (TTP-HUS) registry: a community perspective of patients with clinically diagnosed TTP-HUS
2004
Cancer Statistics, 2006
2006 Standout
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Effect of pegylation on pharmaceuticals
2003 Standout
Transfusion Iron Overload in Adults with Acute Leukemia: Manifestations and Therapy
2000
Pegaspargase: An Alternative?
1997
Transplantation-associated thrombotic microangiopathy after steroid pulse therapy for polyserositis related to graft-versus-host disease
2010 StandoutNobel
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
2001 StandoutNature
Allogeneic hematopoietic cell transplantation for patients with high-risk acute lymphoblastic leukemia in first or second complete remission using fractionated total-body irradiation and high-dose etoposide: A 15-year experience
2003
Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemia
2002
Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia
2001
Pharmacokinetic evaluation of high-dose etoposide phosphate after a 2-hour infusion in patients with solid tumors
1996
Phase I evaluation of a water-soluble etoposide prodrug, etoposide phosphate, given as a 5-minute infusion on days 1, 3, and 5 in patients with solid tumors.
1994
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Vincristine sulfate for the treatment of thrombotic thrombocytopenic purpura refractory to plasma‐exchange
1994
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes
2001
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Defining the Intensity of Conditioning Regimens: Working Definitions
2009 Standout
The biology and therapy of adult acute lymphoblastic leukemia
2003
Disseminated Intravascular Coagulation
1999 Standout
Treatment of Acute Lymphoblastic Leukaemia
2007
HLA‐DR53 protects against thrombotic thrombocytopenic purpura/adult hemolytic uremic syndrome
1994
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura
1998 Standout
Increasing mortality from thrombotic thrombocytopenic purpura in the United States—analysis of national mortality data, 1968–1991
1995
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Haemolytic-uraemic syndrome in practice
1994
Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.
2001
Intensified and Shortened Cyclical Chemotherapy for Adult Acute Lymphoblastic Leukemia
2002
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia [see comments]
1992
Cancer treatment and survivorship statistics, 2016
2016 Standout
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
Cancer treatment and survivorship statistics, 2019
2019 Standout
The biology and treatment of acute lymphoblastic leukemia in adults
1995
How I treat patients with thrombotic thrombocytopenic purpura–hemolytic uremic syndrome
2000
Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development
2014 StandoutNobel
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
1998 Standout
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
1997
Transfusion Iron Overload in Adults with Acute Leukemia: Manifestations and Therapy
2000
Cancer treatment and survivorship statistics, 2014
2014 Standout
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout
Works of CA Linker being referenced
Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report
1991
Improved results of treatment of adult acute lymphoblastic leukemia
1987
Improved results of treatment of adult acute lymphoblastic leukemia
1987
Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic
1992
Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimen
1993
Post-remission cytopenias following intense induction chemotherapy for acute myeloid leukemia.
1994
Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic
1992